Fox Christine, EVP of U.S. Commercial at Teva Pharmaceutical Industries Ltd. ($TEVA), sold nearly $2 million worth of company shares on the open market in four transactions over the last year. Her most recent sale occurred on March 5, 2026. These sales rank her 3,502nd among 11,678 insiders in our database by total value sold, below the average of $8.6 million per insider and 6.4 transactions. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, U.S. Commercial | M | Ordinary Shares | 17819 | $0.00 | 92,829.0000 | 1,163,000,000 | 23.76% | 0.00% |
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, U.S. Commercial | M | Restricted Share Units | 17819 | $0.00 | 53,459.0000 | 1,163,000,000 | 25.00% | 0.00% |
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, U.S. Commercial | S | Ordinary Shares | 7924 | $31.67 | 84,905.0000 | 1,163,000,000 | 8.54% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, U.S. Commercial | M | Ordinary Shares | 20461 | $0.00 | 84,108.0000 | 1,163,000,000 | 32.15% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, U.S. Commercial | A | Restricted Share Units | 50643 | $0.00 | 50,643.0000 | 1,163,000,000 | 9999.99% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, U.S. Commercial | M | Restricted Share Units | 20461 | $0.00 | 40,923.0000 | 1,163,000,000 | 33.33% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, U.S. Commercial | S | Ordinary Shares | 9098 | $32.46 | 75,010.0000 | 1,163,000,000 | 10.82% | 0.00% |
| Nov. 20, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | M | Ordinary Shares | 63492 | $0.00 | 91,876.0000 | 1,164,000,000 | 223.69% | 0.01% |
| Nov. 20, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | S | Ordinary Shares | 28229 | $24.78 | 63,647.0000 | 1,164,000,000 | 30.73% | 0.00% |
| Nov. 20, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | M | Restricted Share Units | 63492 | $0.00 | 126,984.0000 | 1,164,000,000 | 33.33% | 0.01% |
| Nov. 14, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | S | Ordinary Shares | 30000 | $25.11 | 28,384.0000 | 1,164,000,000 | 51.38% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | A | Restricted Share Units | 71278 | $0.00 | 71,278.0000 | 1,131,000,000 | 9999.99% | 0.01% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | S | Ordinary Shares | 4034 | $15.73 | 60,531.0000 | 1,131,000,000 | 6.25% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | M | Restricted Share Units | 20461 | $0.00 | 61,384.0000 | 1,131,000,000 | 25.00% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | S | Ordinary Shares | 2147 | $15.91 | 58,384.0000 | 1,131,000,000 | 3.55% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | M | Ordinary Shares | 20461 | $0.00 | 64,565.0000 | 1,131,000,000 | 46.39% | 0.00% |
| Nov. 20, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | M | Restricted Share Units | 63492 | $0.00 | 190,476.0000 | 1,133,000,000 | 25.00% | 0.01% |
| Nov. 20, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | S | Ordinary Shares | 19388 | $16.87 | 44,104.0000 | 1,133,000,000 | 30.54% | 0.00% |
| Nov. 20, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | M | Ordinary Shares | 63492 | $0.00 | 63,492.0000 | 1,133,000,000 | 9999.99% | 0.01% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Fox Christine | EVP, Head of U.S. Commercial | A | Restricted Share Units | 81845 | $0.00 | 81,845.0000 | 1,119,000,000 | 9999.99% | 0.01% |